Amexdrug Corporation
AXRX
$0.002
$0.000.00%
| 06/30/2013 | 03/31/2013 | 12/31/2012 | 09/30/2012 | 06/30/2012 | |
|---|---|---|---|---|---|
| Net Income | 36.88% | 65.51% | 53.93% | -56.48% | -40.92% |
| Total Depreciation and Amortization | 608.00% | 608.00% | 365.38% | 47.06% | 108.33% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -392.31% | 57.14% | 5.77% | -131.82% | 225.00% |
| Change in Net Operating Assets | 154.28% | -211.63% | 142.78% | -7,506.25% | 30.79% |
| Cash from Operations | 259.87% | -2,273.13% | 3,272.60% | -687.82% | 27.22% |
| Capital Expenditure | -- | -- | -3,152.48% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 165.00% | -100.00% | -- | -100.00% |
| Cash from Investing | -- | 45.00% | -3,511.02% | 100.00% | 100.00% |
| Total Debt Issued | -- | -- | -101.65% | -- | -- |
| Total Debt Repaid | -783.51% | 71.55% | -- | 549.01% | 80.91% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -33.33% | 100.00% | -- | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -180.00% | 57.14% | -- |
| Cash from Financing | -264.04% | 71.32% | -103.52% | 1,076.21% | 124.33% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 250.62% | 37.20% | -95.94% | 3,166.67% | 77.25% |
